Melittin‐MIL‐2 injection upregulated IFN‐γ levels as well as inhibited IL‐4 secretion, facilitating the development of Th1 subtypes relative to Th2 cells in lung adenocarcinoma microenvironment. The gene discussed is IL4; the disease is lung adenocarcinoma.